- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request A Presentation
- ADPKD Simulator
- Patient Resources
- Log In
- Join
- Log Out
- Account
Archives
Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Background
- The psychological impact of ADPKD can negatively impact the patient outcomes. Currently there is a paucity of research in this area and as a result, mental health is underrecognized and underdiagnosed in this patient population. Early detection and treatment of mental health can improve quality of life and is as important as medical management. Bringing awareness to this issue is critical to improving the management and overall well-being of these patients.
- Even early on in ADPKD, ADPKD patients report a lower satisfaction with life compared to healthy persons.1
- The goal of this webinar is to increase awareness surrounding the emotional and physical burden that ADPKD patients face. The webinar will also discuss the impact on patient’s caregivers as well as the urgent call to action for collaborative engagement between nephrology and mental health experts to address mental health in ADPKD patients.
- Discuss the psychological impact of ADPKD (i.e., the biological mechanisms behind anxiety and depression in ADPKD) as well as the emotional burden these patients face
- Discuss the quality of life in ADPKD patients and the impact on family and caregivers
- Evaluate the morbidity and mortality outcomes in ADPKD patients
- Assess what HCPs can do better in terms of empowering their ADPKD patients and properly addressing their mental health needs
- Yarlioglu, A.M., et al. Int Urol Nephrol. 2022 https://doi.org/10.1007/s11255-022-03375-2
Featuring
Rebecca S. Ahdoot, MD, FASN
Assistant Professor — Department of NephrologyDirector — PKD Partner Clinic at the UCI School of Medicine*
Dr Rebecca S. Ahdoot is a board-certified UCI Health nephrologist and director of the PKD Partner Clinic at UCI. She specializes in the management of acute and chronic kidney disease, hypertension/high blood pressure, kidney stones, electrolyte abnormalities and dialysis. She earned her medical degree at the UCI School of Medicine and completed an internal medicine residency at Kaiser Permanente Los Angeles Medical Center. She completed a joint neurology fellowship with Kaiser Permanente and Cedars-Sinai in Los Angeles. She also completed the UCLA Kennamer/Kaiser Permanente Community Medicine Fellowship program, which focuses on healthcare policy, patient advocacy and primary care. Dr Ahdoot is passionate about community service and outreach. She founded a bi-annual health fair to address the lack of affordable, timely vision and hearing services for low-income patients. She also has participated in volunteer medical missions to Guatemala through HELPS International.
Hannah Graves, LMSW
Director of Transplant Outreach — Apex Health InnovationsTransplant Social Worker — Piedmont Transplant Institute*
Hannah Graves is a native of Milwaukee, Wisconsin and graduated with a Bachelor of Arts in Psychology in 2009, followed by a Master’s Degree in Social Work from the University of Wisconsin Milwaukee at the Helen Bader School of Social Welfare. Hannah has significant experience working in hospice, short-term rehab and in dialysis from 201-2019. Currently, Hannah works for Apex Health Innovations, a global healthcare technology company, and Piedmont Transplant Institute, supporting patients through their transplant journey.
Moderating
Marla Dallal, PharmD, RPH
Nephrology Clinical & Scientific LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Marla Dallal, PharmD, RPH is a Clinical & Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy in Los Angeles. While in pharmacy school, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.
Jaimini Patel, PharmD, BCCCP
Nephrology Clinical & Scientific LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Jaimini Patel, PharmD, BCCCP, is a Nephrology Clinical and Scientific Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel earned her Doctorate in Pharmacy from the University of Michigan, Ann Arbor and completed two years of post-doctoral residency at Beaumont Hospital, Royal Oak and Loyola University Medical Center, respectively, specializing in critical care pharmacy practice. Prior to joining Otsuka, Dr Patel practiced as a critical care pharmacist at the Cleveland Clinic Akron General Medical Center for 3.5 years and has cared for patients in the medical, surgical/trauma, cardiothoracic and neuroscience ICUs, and was significantly involved in the care of patients with COVID-19. Dr Patel holds board certification in critical care pharmacotherapy and is a licensed pharmacist in Michigan, Illinois and Ohio. She is also an active member of the Society of Critical Care Medicine through which she is engaged in research and leadership.
*Dr Rebecca Ahdoot and Hannah Graves are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Marla Dallal and Jaimini Patel are employees of OPDC.
Registration
Please Log In Or Join to Register for this Event.
Related Resources
-
Depression & Anxiety In End-Stage Kidney Disease
Printable Handouts May 24, 2023This presentation will illuminate the burden of depression and anxiety in ESKD patients and the associated risk factors. Best practices and strategies for recognizing and discussing these concerns with patients…
-
Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Printable Handouts May 24, 2023The goal of this presentation is to increase awareness surrounding the emotional and physical burden that ADPKD patients face. The presentation will also discuss the impact on patient’s caregivers as…
-
Infographic – Understanding Mental Health & Burnout For Health Care Professionals
Infographic May 23, 2023This infographic reviews causative factors and consequences of burnout as well as ways to improve mental health and well-being in the workplace.
Related Events
-
Kidney Healthy Cooking Series Featuring Celebrity Chef JJ: Episode 3
June 6 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2023 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.